Monday, December 23, 2024
HomeTagsTrial of RGX-314

Trial of RGX-314

REGENXBIO Presents Positive Interim Data from Phase II ALTITUDE Trial of RGX-314

REGENXBIO Inc. announced additional positive interim data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy (DR) without...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics